David Young - 05 Aug 2022 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
President & CEO, Director, 10%+ Owner
Signature
/s/ David Young by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
05 Aug 2022
Transactions value $
-$8,023
Form type
4
Filing time
09 Aug 2022, 16:26:42 UTC
Previous filing
05 Jul 2022
Next filing
23 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Options Exercise +7.6K +1.99% 390K 05 Aug 2022 Direct F1
transaction PCSA Common Stock Tax liability -$8.02K -2.53K -0.65% $3.17 387K 05 Aug 2022 Direct
holding PCSA Common Stock 574K 05 Aug 2022 By Young-Plaisance Revocable Trust
holding PCSA Common Stock 695K 05 Aug 2022 By Family Entities
holding PCSA Common Stock 37.5K 05 Aug 2022 By CorLyst, LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting of time-based restricted shares.